Facile and rapid synthesis of highly luminescent nanoparticles via Pulsed Laser Ablation in Liquid

This paper demonstrates the usefulness of pulsed laser ablation in liquids as a fast screening synthesis method able to prepare even complex compositions at the nanoscale. Nanoparticles of Y2O3:Eu3+, Lu2O2S: Eu3+, Gd2SiO5:Ce3+ and Lu3TaO7:Gd3+,Tb3+ are successfully synthesized by pulsed laser ablation in liquids. The phase and stoichiometries of the original materials are preserved while the sizes are reduced down to 5-10 nm. The optical properties of the materials are also preserved but show some small variations and some additional structures which are attributed to the specificities of the nanoscale (internal pressure, inhomogeneous broadening, surface states...

Shells of crystal field symmetries evidenced in oxide nano-crystals

By the use of a point charge model based on the Judd-Ofelt transition theory, the luminescence from Eu3+ ions embedded in Gd2O3 clusters is calculated and compared to the experimental data. The main result of the numerical study is that without invoking any other mechanisms such as crystal disorder, the pure geometrical argument of the symmetry breaking induced by the particle surface has influence on the energy level splitting. The modifications are also predicted to be observable in realistic conditions where unavoidable size dispersion has to be taken into account. The emission spectrum results from the contribution of three distinct regions, a cluster core, a cluster shell and a very surface, the latter being almost completely quenched in realistic conditions. Eventually, by detailing the spectra of the ions embedded at different positions in the cluster we get an estimate of about 0.5 nm for the extent of the crystal field induced Stark effect. Due to the similarity between Y2O3 and Gd2O3, these results apply also to Eu3+ doped Y2O3 nanoparticles

Nouvelles méthodologies pour la synthèse asymétrique de peptides aldéhydiques b3-C-terminaux et de dérivés d'acides aminés disubstitués via hétérocycloaddition

Les peptides aldéhydes sont connus comme inhibiteurs de protéases et précurseurs de différentes classes de composés biologiquement actifs. Les méthodes pour leur synthèse impliquent classiquement la transformation d'un précurseur (amide de Weinreb, ester, alcool, acétal) en aldéhyde en étape finale pour éviter l'épimérisation du stéréocentre en position a de l'aldéhyde. En revanche, les b-peptides aldéhydes, plus stables à l épimérisation, ont été relativement peu explorés. Ils sont généralement obtenus par homologation de l'acide aminé correspondant malgré les faibles rendements, les problèmes d épimérisation et de nombreuses étapes. Par conséquent, un nouvel accès synthétique aux b-peptides aldéhydes reste toujours un challenge difficile. Sur la base des travaux antérieurs dans notre équipe en hétérocycloaddition diastéréosélective [4+2] et [3+2], nous avons développé au cours de ce doctorat de nouvelles stratégies pour l'accès asymétrique à ces dérivés de b-aminoacides par deux voies complémentaires :1) Une voie utilisant les hétérocycles à six chaînons de type 6-ATO (6-alcoxytétrahydrooxazinone) qui ont été préparés par une réaction d hétérocycloaddition hautement stéréosélective avec de bons rendements et ed. Ces cycloadduits ont été transformés par transacétalisation vers les aminoacétals intermédiaires mixtes ou symétriques . Ces nouveaux acétals sont des intermédiaires parfaits pour la N-élongation par couplage peptidique, conduisant finalement aux aldéhydes peptidiques b3-C-terminaux monosubstitués. 2) Sur une autre approche, les hétérocycles à cinq chaînons 5-AISO (3,3'-disubstitué 5-alcoxy-isoxazolidines) ont été obtenus par cycloaddition dipolaire-1,3 entre des cétonitrones esters et des éthers vinyliques. Ces composés ont été utilisés avec succès en tant que précurseurs d'aminoaldéhydes b3-disubstitués après l étape de transprotection de l'atome d'azote, suivie par la copure de la liaison N-O. L extension asymétrique de l'étape de cycloaddition a été étudiée par des voies énantiosélective et diastéréosélective, ouvrant ainsi l'entrée vers les peptides aldéhydiques b3-disubstitués-C-terminaux énantioenrichis.Peptide aldehydes are known as protease inhibitors and precursors for many biologically active compounds. Methods for their synthesis involve classically the transformation of a precursor (Weinreb amide, ester, alcohol, acetal) into an aldehyde as one of the final steps to prevent epimerization of the carbon a to the aldehyde. By contrast, b-peptide aldehydes, more stable to epimerization, have been relatively unexplored. They are usually obtained by homologation of the corresponding amino acid despite low yielding steps, an epimerization problem and low number of accessible amino acids. Therefore, new synthetic access to b-peptide aldehydes is still a challenging problem. On the basis of previous work in our team concerning [4+2] and [3+2] diastereoselective cycloadditions, we have developed during this PhD thesis new strategies for the asymmetric access of b-amino acid derivatives by two complementary ways :1) Original six-membered heterocycles 6-ATO (6-alkoxy-tetrahydrooxazinone ) were prepared by a highly stereoselective heterocycloaddition reaction with good yields and de. These cycloadducts were transformed via transacetalisation into both mixed and symmetrical aminoacetals. Moreover, these new acetals are ideal intermediates for further peptide coupling, leading ultimately to monosubstituted b3-C-terminal peptide aldehydes. 2) By another approach five-membered heterocycles 5-AISO (3,3 -disubstituted 5-alkoxy-isoxazolidines) were obtained via 1,3-dipolar cycloaddition between a-keto ester nitrones and vinyl ether. These compounds were successfully used as precursors of disubstituted b-amino aldehydes after transprotection of the nitrogen atom and N-O cleavage of the isoxazolidine ring. Asymmetric extension of the cycloaddition step was studied by enantioselective and diastereoselective pathways, thus opening unprecedented entry to enantioenriched disubstituted b3,b3-C-terminal peptide aldehydes.LE MANS-BU Sciences (721812109) / SudocSudocFranceF

Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients – the CONNECT Study

SummaryBackgroundThe CONNECT study compared clinician adherence to guideline-recommended secondary prevention therapies prescribed at discharge for patients hospitalized for acute coronary syndrome (ACS) in those managed initially with percutaneous coronary intervention (PCI; revascularized) and those who did not undergo revascularization.MethodsPatients aged greater than or equal to 18 years, hospitalized for a documented ST-segment elevation or non-ST-segment elevation ACS, were enrolled consecutively over 1 month at 238 sites in France.ResultsCompared with revascularized patients (n=870), non-revascularized patients (n=706) were significantly older, and a greater proportion were women, had high-blood pressure, type-2 diabetes or a history of atherothrombotic or cardiac disease, but a smaller proportion had a history of coronary angioplasty. On discharge, non-revascularized patients were prescribed beta-blockers, aspirin, statins, angiotensin-converting enzyme inhibitors or adenosine diphosphate receptor antagonists less frequently than revascularized patients. An adherence score greater than or equal to 80% (at least four of the five recommended agents prescribed at discharge) was found in 96.7% of revascularized patients and 74.4% of non-revascularized patients (P<0.001).ConclusionsDespite a similar or even higher level of cardiovascular risk, non-revascularized ACS patients were prescribed guideline-recommended secondary prevention therapy less frequently than revascularized patients

YAG nano-light sources with high Ce concentration

We investigate the luminescence properties of 10 nm YAG nanoparticles doped with Ce ions at 0.2%, 4% and 13% that are designed as active probes for Scanning Near field Optical Microscopy. They are produced by a physical method without any subsequent treatment, which is imposed by the desired application. The structural analysis reveals the amorphous nature of the particles, which we relate to some compositional defect as indicated by the elemental analysis. The optimum emission is obtained with a doping level of 4%. The emission of the YAG nanoparticles doped at 0.2% is strongly perturbed by the crystalline disorder whereas the 13% doped particles hardly exhibit any luminescence. In the latter case, the presence of Ce4+ ions is confirmed, indicating that the Ce concentration is too high to be incorporated efficiently in YAG nanoparticles in the trivalent state. By a unique procedure combining cathodoluminescence and Rutherford backscattering spectrometry, we demonstrate that the enhancement of the particles luminescence yield is not proportional to the doping concentration, the emission enhancement being larger than the Ce concentration increase. Time-resolved photoluminescence reveals the presence of quenching centres likely related to the crystalline disorder as well as the presence of two distinct Ce ions populations. Eventually, nano-cathodoluminescence indicates that the emission and therefore the distribution of the doping Ce ions and of the defects are homogeneous

New iron tetrazolate frameworks : synthesis temperature effect, thermal behaviour, Mössbauer and magnetic studies

The exploration of the FeF3/FeF2-Hamtetraz-HF system in dimethylformamide by solvothermal synthesis evidences two isostructural 3D hybrid fluoroferrates. They are prepared from the same starting mixture at two different synthesis temperatures: 120 °C for [Hdma]·(Fe4IIFeIIIF8(H2O)2(amtetraz)4) (1) and 140 °C for [Hdma]1.5·(Fe4.5IIFe0.5IIIF7(H2O)(HCOO)(amtetraz)4) (2). Both compounds are characterized by single crystal X-ray diffraction, X-ray thermodiffraction, TGA analysis, Mössbauer spectrometry and SQUID magnetometry. They crystallize in the monoclinic system and are built from two distinct chains connected by aminotetrazolate anions. The first chain ∞(FeIIFN4) is common to 1 and 2 and can be found in numerous fluorides. In the second chain ∞(Fe3X12) (X = F, N, O), iron cations adopt both valence states Fe(II)/Fe(III). The hydrolysis of DMF implies the formation of a [Hdma]+ cation and a (HCOO)− anion. The presence of Fe3+ in both phases is evidenced by 57Fe Mössbauer spectrometry. The magnetic properties are studied and two transitions from a paramagnetic regime to a long range ordered state below 30 K and 5 K are identified.PostprintPeer reviewe

Correction: Metal complexes as a promising source for new antibiotics

Correction for ‘Metal complexes as a promising source for new antibiotics’ by Angelo Frei et al., Chem. Sci., 2020, 11, 2627–2639

Metal complexes as a promising source for new antibiotics

There is a dire need for new antimicrobial compounds to combat the growing threat of widespread antibiotic resistance. With a currently very scarce drug pipeline, consisting mostly of derivatives of known antibiotics, new classes of antibiotics are urgently required. Metal complexes are currently in clinical development for the treatment of cancer, malaria and neurodegenerative diseases. However, only little attention has been paid to their application as potential antimicrobial compounds. We report the evaluation of 906 metal-containing compounds that have been screened by the Community for Open Antimicrobial Drug Discovery (CO-ADD) for antimicrobial activity. Metal-bearing compounds display a significantly higher hit-rate (9.9%) when compared to the purely organic molecules (0.87%) in the CO-ADD database. Out of 906 compounds, 88 show activity against at least one of the tested strains, including fungi, while not displaying any cytotoxicity against mammalian cell lines or haemolytic properties. Herein, we highlight the structures of the 30 compounds with activity against Gram-positive and/or Gram-negative bacteria containing Mn, Co, Zn, Ru, Ag, Eu, Ir and Pt, with activities down to the nanomolar range against methicillin resistant S. aureus (MRSA). 23 of these complexes have not been reported for their antimicrobial properties before. This work reveals the vast diversity that metal-containing compounds can bring to antimicrobial research. It is important to raise awareness of these types of compounds for the design of truly novel antibiotics with potential for combatting antimicrobial resistance

A community resource for paired genomic and metabolomic data mining

Genomics and metabolomics are widely used to explore specialized metabolite diversity. The Paired Omics Data Platform is a community initiative to systematically document links between metabolome and (meta)genome data, aiding identification of natural product biosynthetic origins and metabolite structures.Peer reviewe